122 related articles for article (PubMed ID: 3988127)
1. Rapid distribution of adriamycin in the ascitic and pleural fluid of women with ovarian carcinomas.
Lazo JS; Schwartz PE
Gynecol Oncol; 1985 May; 21(1):65-72. PubMed ID: 3988127
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin levels in the serum and ascites of patients with ovarian cancer.
Gotlieb WH; Bruchim I; Ben-Baruch G; Davidson B; Zeltser A; Andersen A; Olsen H
Eur J Surg Oncol; 2007 Mar; 33(2):213-5. PubMed ID: 17174514
[TBL] [Abstract][Full Text] [Related]
3. Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases.
Vaksman O; Davidson B; Tropé C; Reich R
Hum Pathol; 2013 Dec; 44(12):2677-83. PubMed ID: 24060004
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma.
Canal P; Bugat R; Michel C; Roche H; Soula G; Combes PF
Cancer Chemother Pharmacol; 1985; 15(2):149-52. PubMed ID: 4017164
[TBL] [Abstract][Full Text] [Related]
5. Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography.
Cummings J; Stuart JF; Calman KC
J Chromatogr; 1984 Nov; 311(1):125-33. PubMed ID: 6520153
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration.
Eksborg S; Stendahl U; Lönroth U
Eur J Clin Pharmacol; 1986; 30(5):629-31. PubMed ID: 3463510
[TBL] [Abstract][Full Text] [Related]
7. Topotecan lacks third space sequestration.
Gelderblom H; Loos WJ; Verweij J; de Jonge MJ; Sparreboom A
Clin Cancer Res; 2000 Apr; 6(4):1288-92. PubMed ID: 10778953
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer.
Ozols RF; Locker GY; Doroshow JH; Grotzinger KR; Myers CE; Young RC
Cancer Res; 1979 Aug; 39(8):3209-14. PubMed ID: 455305
[No Abstract] [Full Text] [Related]
9. The kinetics of cefuroxime in ascitic and pleural fluid.
Lechi A; Arosio E; Xerri L; Mengoli C; Montesi G; Ghidini O
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):493-6. PubMed ID: 6815108
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
[TBL] [Abstract][Full Text] [Related]
11. Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property.
Jandu N; Richardson M; Singh G; Hirte H; Hatton MW
Int J Gynecol Cancer; 2006; 16(4):1536-44. PubMed ID: 16884362
[TBL] [Abstract][Full Text] [Related]
12. [Deviations in glycoprotein contents in malignant ascitic fluid and pleural effusions].
Ohtani H
Rinsho Byori; 1983 Sep; 31(9):940-4. PubMed ID: 6663770
[No Abstract] [Full Text] [Related]
13. Role of cancer antigen-125 from pleural & ascitic fluid samples in non malignant conditions.
Kalantri Y; Naik G; Joshi SP; Jain A; Phatak S; Chavan R; Hemvani N; Chitnis DS
Indian J Med Res; 2007 Jan; 125(1):25-30. PubMed ID: 17332654
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic studies on THP-ADM (tetrahydropyranyl adriamycin)].
Majima H
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):865-70. PubMed ID: 3566297
[TBL] [Abstract][Full Text] [Related]
15. Enhanced chemosensitivity of cells from malignant effusions under condition of exposure to high temperature.
Akiyoshi T; Wada T; Arinaga S; Koba F; Tsuji H
Jpn J Surg; 1986 Sep; 16(5):323-9. PubMed ID: 3099042
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside transporters are widely expressed in ovarian carcinoma effusions.
Bock AJ; Dong HP; Tropé CG; Staff AC; Risberg B; Davidson B
Cancer Chemother Pharmacol; 2012 Feb; 69(2):467-75. PubMed ID: 21822668
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical detection of P-glycoprotein in the management of malignant effusions.
Athanassiadou P; Athanassiades P; Petrakakou E; Zerva C; Mavrikakis M
J Cancer Res Clin Oncol; 1997; 123(8):456-60. PubMed ID: 9292710
[TBL] [Abstract][Full Text] [Related]
18. [Significance of ferritin determination in pleural effusions and ascitic fluid].
Yu SY
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Feb; 8(1):28-30, 61. PubMed ID: 3996130
[No Abstract] [Full Text] [Related]
19. [Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine after intraperitoneal administration].
Noda T; Oku M; Kiyozuka Y; Maruyama M; Adachi S; Akada S; Okamura Y; Ichijo M
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2929-35. PubMed ID: 3178241
[TBL] [Abstract][Full Text] [Related]
20. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
